左乙拉西坦在连续性肾脏替代治疗中的应用 - Suppr

Suppr

超能文献

Levetiracetam Use With Continuous Renal Replacement Therapy.

作者信息

Louie Jessica M, Raphael Kalani L, Barker Brian

出版信息

Ann Pharmacother. 2015 Sep;49(9):1079-80. doi: 10.1177/1060028015591845. Epub 2015 Jun 23.

DOI:10.1177/1060028015591845

PMID:26104053

Abstract

摘要

相似文献

Levetiracetam Use With Continuous Renal Replacement Therapy.

Ann Pharmacother. 2015 Sep;49(9):1079-80. doi: 10.1177/1060028015591845. Epub 2015 Jun 23.

Levetiracetam Pharmacokinetics in a Patient Receiving Continuous Venovenous Hemofiltration and Venoarterial Extracorporeal Membrane Oxygenation.

Pharmacotherapy. 2015 Aug;35(8):e127-30. doi: 10.1002/phar.1615. Epub 2015 Aug 3.

The association between renal replacement therapy modality and long-term outcomes among critically ill adults with acute kidney injury: a retrospective cohort study*.

Crit Care Med. 2014 Apr;42(4):868-77. doi: 10.1097/CCM.0000000000000042.

Nonrenal indications for continuous renal replacement therapy: A report from the Prospective Pediatric Continuous Renal Replacement Therapy Registry Group.

Pediatr Crit Care Med. 2012 Sep;13(5):e299-304. doi: 10.1097/PCC.0b013e31824fbd76.

Evolution and mortality risk factors in children with continuous renal replacement therapy after cardiac surgery.

Rev Esp Cardiol (Engl Ed). 2012 Sep;65(9):795-800. doi: 10.1016/j.recesp.2011.12.009. Epub 2012 Apr 25.

Utilisation and outcome of renal replacement therapy in an Asian tertiary intensive care unit.

Hong Kong Med J. 2011 Dec;17(6):446-52.

Validity of low-intensity continuous renal replacement therapy*.

Crit Care Med. 2013 Nov;41(11):2584-91. doi: 10.1097/CCM.0b013e318298622e.

Timing of continuous renal replacement therapy and mortality in critically ill children*.

Crit Care Med. 2014 Apr;42(4):943-53. doi: 10.1097/CCM.0000000000000039.

Protein and calorie prescription for children and young adults receiving continuous renal replacement therapy: a report from the Prospective Pediatric Continuous Renal Replacement Therapy Registry Group.

Crit Care Med. 2008 Dec;36(12):3239-45. doi: 10.1097/CCM.0b013e31818f3f40.

Risks and benefits of citrate anticoagulation for continuous renal replacement therapy.

Hong Kong Med J. 2015 Apr;21(2):149-54. doi: 10.12809/hkmj144330. Epub 2014 Dec 5.

引用本文的文献

Levetiracetam dosing in continuous renal replacement therapy: A systematic review and development of a novel pharmacokinetic model to optimise dosing in critically ill patients. Do recommended doses achieve therapeutic drug concentrations?

J Intensive Care Soc. 2025 Feb 24;26(2):193-204. doi: 10.1177/17511437251320557. eCollection 2025 May.

A Clinician's Guide to Dosing Analgesics, Anticonvulsants, and Psychotropic Medications in Continuous Renal Replacement Therapy.

Kidney Int Rep. 2021 May 13;6(8):2033-2048. doi: 10.1016/j.ekir.2021.05.004. eCollection 2021 Aug.

Levetiracetam Pharmacokinetics in a Critically Ill Anephric Patient on Intermittent Hemodialysis.

Neurocrit Care. 2018 Apr;28(2):243-246. doi: 10.1007/s12028-017-0441-4.

Levetiracetam Pharmacokinetics in a Patient with Intracranial Hemorrhage Undergoing Continuous Veno-Venous Hemofiltration.

Am J Case Rep. 2017 Apr 27;18:458-462. doi: 10.12659/ajcr.902709.

Antiepileptic Drug Removal by Continuous Renal Replacement Therapy: A Review of the Literature.

Clin Drug Investig. 2017 Jan;37(1):7-23. doi: 10.1007/s40261-016-0457-0.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验